James Gallagher

3.3k total citations · 2 hit papers
41 papers, 2.2k citations indexed

About

James Gallagher is a scholar working on Epidemiology, Oncology and Education. According to data from OpenAlex, James Gallagher has authored 41 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Epidemiology, 7 papers in Oncology and 6 papers in Education. Recurrent topics in James Gallagher's work include Online and Blended Learning (4 papers), Herpesvirus Infections and Treatments (4 papers) and Virus-based gene therapy research (3 papers). James Gallagher is often cited by papers focused on Online and Blended Learning (4 papers), Herpesvirus Infections and Treatments (4 papers) and Virus-based gene therapy research (3 papers). James Gallagher collaborates with scholars based in United States and United Kingdom. James Gallagher's co-authors include Jean Klášterský, Edward Rubenstein, Ronald Feld, James A. Talcott, Michael Boyer, Marianne Paesmans, Bernardo L. Rapoport, Kenneth V. I. Rolston, Jørn Herrstedt and Linda S. Elting and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Journal of Clinical Oncology.

In The Last Decade

James Gallagher

34 papers receiving 2.0k citations

Hit Papers

The Multinational Association for Supportive Care in Canc... 1996 2026 2006 2016 2000 1996 250 500 750

Peers

James Gallagher
Comparison fields: 5 of 107
  • Oncology 1.2k
  • Surgery 643
  • Epidemiology 622
  • Pulmonary and Respiratory Medicine 452
  • Clinical Biochemistry 385
Replace Marcus Hentrich with:
Marcus Hentrich Germany
Andreas Hirt Switzerland
Benjamin Lichtiger United States
Milena Villarroel Chile
Donald J. Higby United States
Rasim Gucalp United States
Maureen Reiner United States
G Todeschini Italy
Carola Arndt United States
Ronald Sobecks United States
Marcus Hentrich Germany View profile →
Citations per field, relative to James Gallagher
James Gallagher · 1×
Citations per year, relative to James Gallagher
James Gallagher · 1×

Countries citing papers authored by James Gallagher

Since Specialization
Citations

This map shows the geographic impact of James Gallagher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Gallagher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Gallagher more than expected).

Fields of papers citing papers by James Gallagher

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James Gallagher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Gallagher. The network helps show where James Gallagher may publish in the future.

Co-authorship network of co-authors of James Gallagher

This figure shows the co-authorship network connecting the top 25 collaborators of James Gallagher. A scholar is included among the top collaborators of James Gallagher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James Gallagher. James Gallagher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1 0
2
Healthcare products trade and external shocks: The US-China trade war and COVID-19 pandemics
2
3 8
4 1
5 0
6
Online Learning: Strategy or Sophistry?
1
7 24
8
Interactive Case Study Experiences Applied to the Managed Learning Environment
4
9
The Multinational Association for Supportive Care in Cancer Risk Index: A Multinational Scoring System for Identifying Low-Risk Febrile Neutropenic Cancer Patients breakdown →
768
10
A Phase I study of continuous infusion doxorubicin and paclitaxel chemotherapy with granulocyte colony-stimulating factor for relapsed epithelial ovarian cancer.
17
11
Epidermoid anal cancer: Results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin breakdown →
581
12 42
13 11
14 1
15 1
16 2
17 11
18 6
19 75
20 16

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026